Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xi Shi

Showing results (321-330 of 344) with videos related to

Pageof 35
Sort By:
Frontiers in Public Health|April 18, 2022
System Architecture of a European Platform for Health Policy Decision Making: MIDASXi Shi, Gorana Nikolic, Scott Fischaber, et al.
The Oncologist|June 14, 2020
Apatinib plus Chemotherapy as a Second-Line Treatment in Unresectable Non-Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical TrialZongyang Yu, Xiuyu Cai, Zhengwu Xu, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2016
Identification of potent and selective MTH1 inhibitorsAlessia Petrocchi, Elisabetta Leo, Naphtali J Reyna, et al.
Science (New York, N.Y.)|September 1, 2018
Engineered CRISPR-Cas9 nuclease with expanded targeting spaceHiroshi Nishimasu, Xi Shi, Soh Ishiguro, et al.
Genome Biology|March 5, 2021
Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneityMatan Sorek, Walaa Oweis, Malka Nissim-Rafinia, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
A machine-learning-guided hydrogen-bonded organic framework for long-term, ultrasound-triggered pain therapyWeilong He, Cathy Yang, Xi Shi, et al.
Blood|July 27, 2016
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genesK Martin Kortüm, Elias K Mai, Nur H Hanafiah, et al.
Cell Regeneration (London, England)|August 7, 2015
GATA2(-/-) human ESCs undergo attenuated endothelial to hematopoietic transition and thereafter granulocyte commitmentKe Huang, Juan Du, Ning Ma, et al.
Science Translational Medicine|May 22, 2020
Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndromePatrick K McCamphill, Laura J Stoppel, Rebecca K Senter, et al.
Cell Reports|August 2, 2023
SLC38A5 aggravates DC-mediated psoriasiform skin inflammation via potentiating lysosomal acidificationLeqing Zhu, Xichun Xia, Guangqiang Li, et al.
Pageof 35

Showing results (321-330 of 344) with videos related to

Sort By:
Pageof 35
Frontiers in Public Health|April 18, 2022
System Architecture of a European Platform for Health Policy Decision Making: MIDASXi Shi, Gorana Nikolic, Scott Fischaber, et al.
The Oncologist|June 14, 2020
Apatinib plus Chemotherapy as a Second-Line Treatment in Unresectable Non-Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical TrialZongyang Yu, Xiuyu Cai, Zhengwu Xu, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2016
Identification of potent and selective MTH1 inhibitorsAlessia Petrocchi, Elisabetta Leo, Naphtali J Reyna, et al.
Science (New York, N.Y.)|September 1, 2018
Engineered CRISPR-Cas9 nuclease with expanded targeting spaceHiroshi Nishimasu, Xi Shi, Soh Ishiguro, et al.
Genome Biology|March 5, 2021
Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneityMatan Sorek, Walaa Oweis, Malka Nissim-Rafinia, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
A machine-learning-guided hydrogen-bonded organic framework for long-term, ultrasound-triggered pain therapyWeilong He, Cathy Yang, Xi Shi, et al.
Blood|July 27, 2016
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genesK Martin Kortüm, Elias K Mai, Nur H Hanafiah, et al.
Cell Regeneration (London, England)|August 7, 2015
GATA2(-/-) human ESCs undergo attenuated endothelial to hematopoietic transition and thereafter granulocyte commitmentKe Huang, Juan Du, Ning Ma, et al.
Science Translational Medicine|May 22, 2020
Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndromePatrick K McCamphill, Laura J Stoppel, Rebecca K Senter, et al.
Cell Reports|August 2, 2023
SLC38A5 aggravates DC-mediated psoriasiform skin inflammation via potentiating lysosomal acidificationLeqing Zhu, Xichun Xia, Guangqiang Li, et al.
Pageof 35